|
|
|
|
|
|
Sponsors and Collaborators: |
Seoul National University Hospital Korean Cancer Study Group National Cancer Center, Korea Seoul National University Bundang Hospital Samsung Medical Center Asan Medical Center Sevrance Hospital |
Information provided by: | Seoul National University Hospital |
ClinicalTrials.gov Identifier: | NCT00527930 |
Phase II trial of oxaliplatin in combination with S-1(SOX) in patients with recurrent or metastatic breast cancer (MBC) previously treated with or resistant to an anthracycline and taxane
Condition | Intervention | Phase |
Breast Neoplasms |
Drug: TS-1 and Eloxatin |
Phase II |
Genetics Home Reference related topics: | breast cancer |
MedlinePlus related topics: | Breast Cancer Cancer |
ChemIDplus related topics: | Oxaliplatin S 1 (Combination) |
Study Type: | Interventional |
Study Design: | Treatment, Open Label, Single Group Assignment, Safety/Efficacy Study |
Official Title: | Phase II Trial of Oxaliplatin in Combination With S-1(SOX) in Patients With Recurrent or Metastatic Breast Cancer (MBC) Previously Treated With or Resistant to an Anthracycline and Taxane |
Study Start Date: | September 2007 |
S-1 80 mg/m2/day on day 1-14 Oxaliplatin 130 mg/m2 IV for 2 hour on day 1 Every 3 week
Number of Cycles: until progression or unacceptable toxicity
Ages Eligible for Study: | 18 Years and older |
Genders Eligible for Study: | Both |
Accepts Healthy Volunteers: | No |
Inclusion Criteria:
For taxanes (Paclitaxel (P) / Docetaxel (D))
For anthracyclines
Exclusion Criteria:
Contact: Seock-Ah Im, MD, PhD | 82-2-2072-0850 | moisa@snu.ac.kr |
Contact: Jin Hee Yoon, RN | 82-2-2072-1742 ext 108 | jh3315@hanmail.net |
Korea, Republic of | |||||
Seoul National University Hospital | Recruiting | ||||
Seoul, Korea, Republic of, 110-744 |
Seoul National University Hospital |
Korean Cancer Study Group |
National Cancer Center, Korea |
Seoul National University Bundang Hospital |
Samsung Medical Center |
Asan Medical Center |
Sevrance Hospital |
Principal Investigator: | Seock-Ah Im, MD, PhD | Seoul National University Hospital |
Korean Cancer Study Group 
  |
Seoul National University Hospital Cancer Center 
  |
Study ID Numbers: | KCSG-BR-0703, H-0706-009-209 |
First Received: | September 8, 2007 |
Last Updated: | September 8, 2007 |
ClinicalTrials.gov Identifier: | NCT00527930 |
Health Authority: | Korea: Food and Drug Administration |
|
|
|
|